Brighter wins arbitration case against former development partner.

The juridical process between Brighter and its former development partner HotSwap (now renamed to Amundsen Management and Amundsen Engineering) is now concluded. The arbitrator determined, in accordance with Brighter’s claims against the company, that HotSwap has been careless in their efforts. 

– We wouldn’t have carried out this process if we were not confident of our case, but it feels very good that the matter now also is finalized from a legal perspective. Now we can put this behind us and fully focus on the future and the upcoming launch of Actiste, says Truls Sjöstedt, Brighter’s CEO and founder.

In accordance with the ruling Brighter will receive a compensation of SEK 500 000 from HotSwap. Further information regarding this subject can be found in Brighter’s press release issued August 26, 2015 (Swedish only).

Simultaneously, Brighter pursued additional legal actions against HotSwap regarding a patent dispute. In June 2016 Brighter announced that the company secured all rights in the patent dispute and that Hotswap waives all claims to ownership.

For further information, please contact:
Henrik Norström, COO
Phone: 46 733 40 30 45

Truls Sjöstedt, CEO
Phone: 46 709 73 46 00

About Actiste
Brighter’s subscription service solution Actiste® simplifies insulin-treated diabetes by gathering all the most important functions in a connected device with which the diabetic can measure blood sugar levels, set dosage and inject insulin, as well as automatically log and share information.

About Brighter AB (publ)
Brighter develops solutions for data-driven and mobile health services. Through its intellectual property and innovative tools, jDome® and Actiste®, the company creates a more efficient care chain with focus on the individual. The goal is to simplify, streamline and enhance the information flow of relevant and reliable data between the patient and health care professionals. Brighter is initially focused on diabetes care and care for the elderly, but there are opportunities in the future to operate on a broader level, spanning more diseases and treatment approaches. This is done through The Benefit Loop®, Brighter’s cloud-based service that continuously collects, analyzes and shares data on the user's terms.

The Company's shares are listed on NASDAQOMX First North/BRIG. Brighter’s Certified Adviser on Nasdaq OMX First North is Remium Nordic AB +46 (0)8 – 454 32 50,,

This information is information that Brighter AB is obliged to make public pursuant to the EU Market Abuse Regulation. The information was submitted for publication, through the agency of the contact persons set out above, at 08:30 CET on October 12 2016.

About Us

Brighter is a Swedish-based company that, from a unique IP portfolio, creates smart solutions for one of the most serious healthcare problems: changing patient behavior. Chronic diseases such as diabetes are rapidly increasing and account for an increasing share of healthcare costs globally. Brighter's Business Model and Multi-Sided Market Platform - The Benefit Loop™ - is based on the fact that many special interests create value for each other. By increasing access to valid health data, Brighter creates value for all stakeholders in the care chain: patients and close associates, healthcare providers, research, pharmaceutical industry and society. The Company's shares are listed on NASDAQOMX First North/BRIG. Brighter’s Certified Adviser on Nasdaq OMX First North is Remium Nordic Holding AB +46 (0)8 – 454 32 50,,


Documents & Links